{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:34:24Z","timestamp":1789875264036,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10067-025-07626-2","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T07:03:11Z","timestamp":1754722991000},"page":"3959-3965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Difficult-to-Manage Axial Spondyloarthritis According to ASAS Criteria in Reuma-Check Cohort: Frequency, Predictive Factors, and Treatment Patterns"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-1092","authenticated-orcid":false,"given":"Rodrigo","family":"Garcia-Salinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataly","family":"Mejia-Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-7300","authenticated-orcid":false,"given":"Santiago","family":"Ruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Reyes-Jara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Arguello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n Juan","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"7626_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.20917","author":"M Bittar","year":"2024","unstructured":"Bittar M, Deodhar A (2024) Axial spondyloarthritis: a review. JAMA. https:\/\/doi.org\/10.1001\/jama.2024.20917","journal-title":"JAMA"},{"key":"7626_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82:19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"key":"7626_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02100-w","author":"D Wendling","year":"2024","unstructured":"Wendling D (2024) Difficult-to-treat axial spondyloarthritis: a new challenge. Drugs. https:\/\/doi.org\/10.1007\/s40265-024-02100-w","journal-title":"Drugs"},{"key":"7626_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","volume":"80","author":"G Nagy","year":"2021","unstructured":"Nagy G, Roodenrijs NM, Welsing PM et al (2021) EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 80:31\u201335. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217344","journal-title":"Ann Rheum Dis"},{"key":"7626_CR5","doi-asserted-by":"publisher","unstructured":"Poddubnyy D, Navarro-Comp\u00e1n V, Torgutalp M et al (2025) The Assessment of SpondyloArthritis International Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis. Ann Rheum Dis. https:\/\/doi.org\/10.1016\/j.ard.2025.01.035","DOI":"10.1016\/j.ard.2025.01.035"},{"key":"7626_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-025-01183-y","author":"AL Ribeiro","year":"2025","unstructured":"Ribeiro AL, Proft F (2025) Unraveling the challenges of difficult-to-treat spondyloarthritis: SPARTAN 2024 annual meeting proceedings. Curr Rheumatol Rep. https:\/\/doi.org\/10.1007\/s11926-025-01183-y","journal-title":"Curr Rheumatol Rep"},{"key":"7626_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/RHU.0000000000001654","volume":"27","author":"R Garc\u00eda Salinas","year":"2021","unstructured":"Garc\u00eda Salinas R, Ruta S, Chichande JT et al (2021) \u201cReuma-Check\u201d: performance of a comprehensive fast-track program for the diagnosis of axial spondyloarthritis in South America. JCR J Clin Rheumatol 27:175\u2013181. https:\/\/doi.org\/10.1097\/RHU.0000000000001654","journal-title":"JCR J Clin Rheumatol"},{"key":"7626_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/1756-185X.14399","volume":"25","author":"R Garcia Salinas","year":"2022","unstructured":"Garcia Salinas R, Jaldin Cespedes R, Gomez RA et al (2022) Non-radiographic axial spondyloarthritis in South America. Burden of disease and differential features with respect to ankylosing spondylitis at time of diagnosis. A comprehensive analysis with a focus on images. Int J Rheum Dis 25:1169\u20131175. https:\/\/doi.org\/10.1111\/1756-185X.14399","journal-title":"Int J Rheum Dis"},{"key":"7626_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10067-024-07299-3","volume":"44","author":"R Garcia-Salinas","year":"2025","unstructured":"Garcia-Salinas R, Reyes-Jara G, Almada F et al (2025) Late-onset axial spondyloarthritis: data from Reuma-check cohort. Clin Rheumatol 44:701\u2013706. https:\/\/doi.org\/10.1007\/s10067-024-07299-3","journal-title":"Clin Rheumatol"},{"key":"7626_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133645","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, Van Der Heijde D, Landew\u00e9 R et al (2011) The assessment of Spondyloarthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard.2010.133645","journal-title":"Ann Rheum Dis"},{"key":"7626_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.110767","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Jurik AG, Hermann KGA et al (2009) Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI group. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard.2009.110767","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"7626_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/ard.60.7.641","volume":"60","author":"M Backhaus","year":"2001","unstructured":"Backhaus M, Burmester GR, Gerber T et al (2001) Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 60(7):641\u2013649. https:\/\/doi.org\/10.1136\/ard.60.7.641","journal-title":"Ann Rheum Dis"},{"key":"7626_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105670","author":"C Philippoteaux","year":"2024","unstructured":"Philippoteaux C, Delepine T, Cailliau E et al (2024) Characteristics of difficult-to-treat axial spondyloarthritis: results of a real-world multicentric study. Joint Bone Spine. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105670","journal-title":"Joint Bone Spine"},{"key":"7626_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003461","author":"O Fakih","year":"2023","unstructured":"Fakih O, Desmarets M, Martin B et al (2023) Difficult-to-treat axial spondyloarthritis is associated with psoriasis, peripheral involvement and comorbidities: results of an observational nationwide study. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2023-003461","journal-title":"RMD Open"},{"key":"7626_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf120","author":"ML Smits","year":"2025","unstructured":"Smits ML, Webers C, Vonkeman HE, van Tubergen A (2025) Exploring difficult-to-manage axial spondyloarthritis: results from a Dutch clinical practice registry. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keaf120","journal-title":"Rheumatology"},{"key":"7626_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","volume":"20","author":"T Rusman","year":"2018","unstructured":"Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE (2018) Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep 20:35. https:\/\/doi.org\/10.1007\/s11926-018-0744-2","journal-title":"Curr Rheumatol Rep"},{"key":"7626_CR17","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1097\/RHU.0000000000002063","volume":"30","author":"R Garcia-Salinas","year":"2024","unstructured":"Garcia-Salinas R, Reyes Jara G, Arguello J et al (2024) Clinical, laboratory, and imaging features between men and women with axial spondyloarthritis in a specialized center in Argentina. JCR J Clin Rheumatol 30:e105\u2013e107. https:\/\/doi.org\/10.1097\/RHU.0000000000002063","journal-title":"JCR J Clin Rheumatol"},{"key":"7626_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.46497\/ArchRheumatol.2024.10567","volume":"39","author":"TS \u00d6\u011f\u00fct","year":"2024","unstructured":"\u00d6\u011f\u00fct TS, Erbasan F, \u015eahiner MF et al (2024) Difficult-to-treat axial spondyloarthritis patients. Arch Rheumatol 39:419\u2013428. https:\/\/doi.org\/10.46497\/ArchRheumatol.2024.10567","journal-title":"Arch Rheumatol"},{"key":"7626_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae562","author":"R Garcia-Salinas","year":"2024","unstructured":"Garcia-Salinas R, Magri S, Mareco J et al (2024) Arthralgia with risk of progression to psoriatic arthritis: role of clinical assessments and ultrasound as prognostic factors. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keae562","journal-title":"Rheumatology"},{"key":"7626_CR20","doi-asserted-by":"publisher","unstructured":"Zemrani S, Amine B, ElBinoune I et al (2024) Difficult-to-Treat Spondyloarthritis in Morocco: a Real-World Study. Mediterr J Rheumatol 35:549\u2013556. https:\/\/doi.org\/10.31138\/mjr.290124.dtt","DOI":"10.31138\/mjr.290124.dtt"},{"key":"7626_CR21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.31138\/mjr.131124.dma","volume":"35","author":"E Emmanouilidou","year":"2024","unstructured":"Emmanouilidou E, Flouri ID, Bertsias A et al (2024) Difficult-to-Manage Axial Spondyloarthritis. Mediterr J Rheumatol 35:542\u2013548. https:\/\/doi.org\/10.31138\/mjr.131124.dma","journal-title":"Mediterr J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07626-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07626-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07626-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:23:27Z","timestamp":1760365407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07626-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7626"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07626-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Italian Hospital of La Plata (Comit\u00e9 de \u00c9tica del Hospital Italiano de La Plata). All procedures complied with the Declaration of Helsinki and national regulations (Ministerial Resolution 1480\/11). Written informed consent to participate was obtained from all participants prior to enrollment. No animal subjects were involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics statement for the use of human and animal subjects"}},{"value":"Consent for publication was obtained from all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Artificial Intelligence tools (ChatGPT, GPT-4, OpenAI) were used to assist with English editing during manuscript preparation. All outputs generated by AI were carefully reviewed and edited by the authors to ensure accuracy and appropriateness.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of Artificial Intelligence"}},{"value":"Rodrigo Garcia-Salinas has received research grants and\/or consultancy fees from Abbvie, Eli Lilly, Janssen, Novartis, Pfizer, Sanofi, UCB, Roche, Amgen, BMS, and Sandoz. Ruta Santiago has received research grants and\/or consultancy fees from Abbvie, Novartis, Pfizer, and Janssen. Sebastian Magri has received research grants and\/or consultancy fees from GSK, Astra Zeneca, Abbvie, Novartis, and Biogen. Nataly Mejia-Maggi, Gisele Reyes-Jara, and Juan Arguello declare no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}